Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Breast 2Tumor-Agnostic 1Gastrointestinal 1Dermatologic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Constriction, Pathologic 1

Interventions

Cyclophosphamide 73Rituximab 59Specimen Handling 49Biopsy 42Doxorubicin 41Vincristine 40Magnetic Resonance Spectroscopy 39Prednisone 36venetoclax 28obinutuzumab 27fludarabine 26ibrutinib 22Methotrexate 22Dexamethasone 21Cytarabine 21Lenalidomide 20blinatumomab 19Etoposide 19merphos 17zanubrutinib 16acalabrutinib 16prednylidene 15fludarabine phosphate 15deltacortene 15X-Rays 14Mercaptopurine 14Bendamustine Hydrochloride 14pegaspargase 13Calcium Dobesilate 13CT-P10 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Therapeutics × Lymphoid × 30 days × Clear all
NCT07621406 2026-06-02

Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma

The First Affiliated Hospital of Soochow University

Phase 2 Active not recruiting
25 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05149755 2026-05-19

Evolutâ„¢ EXPAND TAVR II Pivotal Trial

Medtronic Cardiovascular

Phase NA Active not recruiting
650 enrolled
Lymphoid

Constriction, Pathologic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡